Analysis-Bets surge against Nike, heaping pressure on CEO Hill

Nike is losing share in global sports footwear, with its market share down 3 percentage points to 22.9% in 2025, while Adidas rose to 12.2% from 11.7% in 2024. Short interest has jumped sharply, with 4.67% of Nike shares on loan as of May 1 versus 0.41% when Elliott Hill took over in October 2024, and the stock recently closed at $43.09, its lowest since 2014. Inventory remains elevated at 16.1% of revenue and margins are still under pressure, though management says the core-sports turnaround is only beginning to execute.

Analysis

This is less a one-quarter story than a margin-duration problem: when a brand loses pricing power, the earnings drag compounds because distribution, marketing, and inventory cleanup all move in the wrong direction at once. The market is likely underappreciating how long it takes for a footwear franchise to rebuild “must-own” status once consumer trial shifts to a competitor’s platform shoe and the retailer ecosystem starts allocating shelf space elsewhere. That creates a second-order winner set beyond the obvious rival: premium running specialty channels, as well as smaller brands with faster product cycles, can keep compounding share even if the macro consumer backdrop softens.

The real risk for Nike is that improving unit economics may lag unit sell-through by several quarters. Deeper markdowns can temporarily stabilize shelf velocity, but they also teach consumers to wait for discounts, which resets the reference price and lowers future full-price conversion. That is the key bear case: even if inventory normalizes in the next 2-3 quarters, gross margin recovery may not follow until FY26, because promotional elasticity and channel restocking both need to heal.

A near-term catalyst for upside would be evidence that new running launches are pulling incremental consumers rather than just replacing legacy demand; absent that, short interest can keep rising as a self-reinforcing signal of skepticism. The contrarian view is that this is now a crowded bearish narrative: if management can show two consecutive quarters of stable inventories and expanding full-price mix, the stock could re-rate sharply off depressed expectations. But that upside is tactical, not structural, unless the company proves it can generate repeatable product hits again.

For competitors, the biggest second-order effect is not just share capture but negotiation leverage with wholesalers and specialty retailers, who will likely demand better terms from laggards and give better placement to brands with fresher demand. That should support relative gross margins and marketing efficiency for the winners, while Nike may need to spend more just to hold share. In that setup, the best trade is not simply buying the leaders, but fading the laggard until the market sees evidence that innovation is translating into sustained category-wide sell-through.

Key Decisions for Investors

• Short NKE into any relief rally over the next 2-6 weeks; target a move toward prior cycle support, with risk defined above the post-earnings gap if management delivers a credible inventory inflection
• Pair trade: long DECK / short NKE for 1-3 months to express winner/loser dispersion in premium athletic footwear; thesis is faster product innovation and better sell-through at the expense of a slower turnaround story
• If options liquidity is sufficient, buy NKE put spreads 2-4 months out to capture continued multiple compression while capping premium outlay; best risk/reward if implied volatility stays elevated but not extreme
• Avoid chasing long-only exposure to athletic footwear until two consecutive quarters show improving full-price mix and inventory-to-revenue downtrend; otherwise the turnaround remains a value trap
• For investors already long NKE, consider trimming and re-entering only after evidence of category breadth beyond running/soccer, because isolated product wins are unlikely to change the earnings trajectory